Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma-Reference-Cited by-同舟云学术

Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma

Published:2015-09 Issue:9 Volume:21 Page:1583-1588
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Chen Yi-Bin,Li Shuli,Fisher David C.,Driscoll Jessica,Del Rio Candice,Abramson Jeremy,Armand Philippe,Barnes Jeffrey,Brown Jennifer,Cutler Corey,El-Jawahri Areej,Ho Vincent T.,Hochberg Ephraim,McAfee Steven,Takvorian Ronald,Spitzer Thomas R.,Antin Joseph H.,Soiffer Robert,Jacobsen Eric

Funder

Otsuka Pharmaceuticals, Inc

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference30 articles.

1. Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC;Touzeau;Ann Hematol,2014

2. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur;Geisler;Br J Haematol,2012

3. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01;d'Amore;J Clin Oncol,2012

4. Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors;Telio;Leuk Lymphoma,2012

5. Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial;Guglielmi;J Clin Oncol,1998

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2022-07

2. Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma;Bone Marrow Transplantation;2022-03-08

3. Long-term remissions in patients with early relapse of diffuse large B-cell lymphoma following high-dose chemotherapy, autologous stem cell transplantation, and radiotherapy of residual disease;Strahlentherapie und Onkologie;2021-11-04

4. HSCT in Malignancies;Contemporary Bone Marrow Transplantation;2021

5. Hematopoietic Progenitor Cell Transplantation in Children, Adolescents, and Young Adults With Relapsed Mature B-Cell NHL;Journal of the National Comprehensive Cancer Network;2020-08